NCCN guidelines ® insights hodgkin lymphoma, version 1.2018 featured updates to the NCCN guidelines

Richard T. Hoppe, Ranjana H. Advani, Weiyun Z. Ai, Richard F. Ambinder, Patricia Aoun, Philippe Armand, Celeste M. Bello, Cecil M. Benitez, Philip J. Bierman, Robert Chen, Bouthaina Dabaja, Robert Dean, Andres Forero, Leo I. Gordon, Francisco J. Hernandez-Ilizaliturri, Ephraim P. Hochberg, Jiayi Huang, Patrick B. Johnston, Mark S. Kaminski, Vaishalee P. KenkreNadia Khan, Kami Maddocks, David G. Maloney, Monika Metzger, Joseph O. Moore, David Morgan, Craig H. Moskowitz, Carolyn Mulroney, Rachel Rabinovitch, Stuart Seropian, Randa Tao, Jane N. Winter, Joachim Yahalom, Jennifer L. Burns, Ndiya Ogba

Research output: Contribution to journalArticlepeer-review

33 Scopus citations

Abstract

The NCCN Clinical Practice Guidelines in Oncology for Hodgkin Lymphoma (HL) provide recommendations for the management of adult patients with HL. The NCCN Guidelines Panel meets at least annually to review comments from reviewers within the NCCN Member Institutions, examine relevant data, and reevaluate and update the recommendations. These NCCN Guidelines Insights summarize recent updates centered on treatment considerations for relapsed/refractory classic HL.

Original languageEnglish (US)
Pages (from-to)245-254
Number of pages10
JournalJNCCN Journal of the National Comprehensive Cancer Network
Volume16
Issue number3
DOIs
StatePublished - Mar 1 2018

ASJC Scopus subject areas

  • Oncology

Fingerprint

Dive into the research topics of 'NCCN guidelines ® insights hodgkin lymphoma, version 1.2018 featured updates to the NCCN guidelines'. Together they form a unique fingerprint.

Cite this